Hepatitis G virus/GB virus C infection in patients with chronic non-B, non-C hepatitis

International Hepatology Communications

Volumn 6, Issue 3-4, 1997, Pages 137-143

  Tanaka, Eiji ^a   Yamaguchi, Kenjiro ^b   Uemura, Kazuyuki ^a   Kobayashi, Masakazu ^a   Iijima, Akihiro ^a   Kiyosawa, Kendo ^a   Yagi, Shintaro ^b   Hasegawa, Akira ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Research and Development Laboratory   (Japan)

Author keywords

chronic hepatitis; hepatocellular carcinoma; HGV GBV C RNA; liver cirrhosis; nested PCR; viral hepatitis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS G; HEPATITIS NON A NON B; HEPATITIS VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031040277     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4346(96)00339-8     Document Type: Article

References (17)

1. [1] Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis virus. Nat Med 1995; 1: 564-569.
2. [2] Linnen J, Wages J Jr. Zhang-Keck Z-Y, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-508.
3. [3] Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996; 334: 1536-1537.
4. [4] Alter HJ, Bradley DW. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Semin Liver Dis 1995; 15: 110-120.
5. [5] Kodali VP, Gordon SC, Silverman AL, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol 1994; 89: 1836-1839.
6. [6] Shih JW-K, Cheung LC, Alter HJ, Lee LM, Gu JR. Strain analysis of hepatitis B virus on the basis of restriction endonuclease analysis of polymerase chain reaction products. J Clin Microbiol 1991; 29: 1640-1644.
7. [7] Tanaka E, Kiyosawa K, Nakatsuji Y, et al. Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in post-transfusion hepatitis patients during long-term follow-up. J Med Virol 1993; 39: 318-324.
8. [8] Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 13-20.
9. [9] Nakatsuji Y, Shih JWK, Tanaka E, et al. Prevalence and disease association of hepatitis G virus infection in Japan. J Viral Hepatitis (in press).
10. [10] Jeffers LJ, Piatak M, Bernstein DE, et al. Hepatitis G virus infection in patients with acute and chronic liver disease of unknown etiology. Hepatology 1995; 22: 182A.
11. [11] Fiordalisi G, Zanella I, Mantero G, et al. High prevalence of GB virus C infection in a group of Italian patients with hepatitis of unknown etiology. J Infect Dis 1996; 174: 181-183.
12. [12] Egawa K, Yukawa T, Arakawa S, et al. Infection with GB virus C in leprous patients in Japan. J Med Virol 1996; 49: 110-114.
13. [13] Wang JT, Tsai FC, Lee CZ, et al. A prospective study of transfusion-transmitted GB virus C infection: Similar frequency but different clinical presentation compared with hepatitis C virus. Blood 1996; 88: 1881-1886.
14. [14] Masuko K, Mitsui T, Iwano K, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-1490.
15. [15] Tanaka E, Alter HJ, Nakatsuji Y, et al. Effect of hepatitis G virus co-infection on patients with chronic hepatitis C. Ann Int Med 1996; 125: 740-743.
16. [16] Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-1132.
17. [17] Mishiro S, Yoshiba M, Okamoto H. GBV-C in the aetiology of fulminant hepatitis (Authors' reply). Lancet 1996; 347: 120-121.